Alembic Limited Stock NSE India S.E.
Equities
ALEMBICLTD
INE426A01027
Real Estate Development & Operations
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
94.05 INR | -0.32% | +2.23% | +3.92% |
04-18 | Alembic Pharmaceuticals Board to Consider Dividend for Fiscal 2024; Shares Drop 3% | MT |
04-02 | Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment | MT |
Sales 2022 | 782M 9.38M 12.8M | Sales 2023 | 1.27B 15.26M 20.82M | Capitalization | 15.22B 183M 249M |
---|---|---|---|---|---|
Net income 2022 | 2.22B 26.63M 36.34M | Net income 2023 | 1.91B 22.85M 31.18M | EV / Sales 2022 | 23.4 x |
Net cash position 2022 | 270M 3.24M 4.42M | Net cash position 2023 | 464M 5.56M 7.58M | EV / Sales 2023 | 11.6 x |
P/E ratio 2022 |
8.37
x | P/E ratio 2023 |
7.99
x | Employees | 271 |
Yield 2022 |
2.49% | Yield 2023 |
3.71% | Free-Float | 27.91% |
1 day | -0.32% | ||
1 week | +2.23% | ||
Current month | +12.70% | ||
1 month | +5.20% | ||
3 months | +1.95% | ||
6 months | +14.77% | ||
Current year | +3.92% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 69 | 88-07-01 | |
Rasesh J. Shah
DFI | Director of Finance/CFO | - | 14-08-12 |
Chairman | 76 | 67-08-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 76 | 67-08-19 | |
Chief Executive Officer | 69 | 88-07-01 | |
Director/Board Member | 44 | 13-04-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 94.05 | -0.32% | 186 666 |
24-04-26 | 94.35 | -0.42% | 579,768 |
24-04-25 | 94.75 | -1.04% | 460,484 |
24-04-24 | 95.75 | +2.08% | 600,677 |
24-04-23 | 93.8 | +1.96% | 618,293 |
Delayed Quote NSE India S.E., April 29, 2024 at 02:03 am
More quotes1st Jan change | Capi. | |
---|---|---|
+36.16% | 27.94B | |
-13.08% | 26.97B | |
+22.01% | 26.95B | |
+3.39% | 25.32B | |
+44.49% | 22.58B | |
+3.28% | 19.59B | |
+6.69% | 19.52B | |
+28.54% | 16.23B | |
-14.54% | 14.98B |
- Stock Market
- Equities
- ALEMBICLTD Stock
- ALEMBICLTD Stock